Sentence examples for flows of pharmaceuticals from inspiring English sources

18 International flows of pharmaceuticals around the world should be tracked, particularly into sub-Saharan Africa, where the capacity for drug quality testing and patient protection is least developed.

Another, more recent achievement is the renewed flow of pharmaceuticals to the country, providing relief to the thousands of patients who have been dying due to lack of access to essential drugs and medical equipment after its import was disrupted as a consequence of the financial sanctions on Iran.

The ideal supply chain will synchronize aggregate patient-level drug demand with the flow of pharmaceuticals from suppliers, reducing inventory investment along the chain, and improving patient care by minimizing supply shortages.

Cocks, Measurement of the flow properties of powders with special reference to die fill, in: International Journal of Pharmaceutics 280 (1–200427 38]27–38] used an experimental shoe die system to characterise the flow behaviour of pharmaceutical powders.

The powder rheometer is a commonly used device for assessing the bulk flow performance of pharmaceutical powders.

This work was aimed at developing a process analytical technology (PAT) method, based on near-infrared spectroscopy (NIR) for the in-line powder flow characterization of pharmaceutical formulations.

The GDR proved to be an effective and convenient tool for examining flow properties of pharmaceutical materials, both pure and mixtures.

The purpose of this paper is to systematically compare and correlate the lubrication effect of two devices, a controlled shear system and a Resonant Acoustic Mixer, on the flow properties of pharmaceutical blends.

Currently, a number of various methods are used for characterizing the flow properties of pharmaceutical powder materials.

Huge retailers see the potential for cheaper goods, major financial institutions see benefits in access to new markets and the free flow of capital, pharmaceutical companies get extended patent protection and perhaps most important, multinational companies with huge amounts of capital see opportunities to shift their global supply chains to maximize their bottom lines.

The most fundamental contact and non-contact forces are then reviewed in detail on their molecular or physical origin, factors which influence these forces, numerical formalisms and modeling strategies to simulate flows and processes of pharmaceutical interest.